H Olsson

发表

Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families.

P. Møller, Å. Borg, N. Loman, 2001, Human molecular genetics.

Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes

A Borg, N Loman, H Olsson, 1998, Cancer.

Sons of men with prostate cancer: their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing.

H. Olsson, O. Bratt, U Kristoffersson, 1997, Urology.

Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.

J Isola, Å. Borg, O. Kallioniemi, 1997, Cancer research.

Tumour biological features of BRCA1-induced breast and ovarian cancer.

Å. Borg, O. Johannsson, H. Olsson, 1997, European journal of cancer.

MYB oncogene amplification in hereditary BRCA1 breast cancer.

J M Trent, J Isola, J. Trent, 2000, Cancer research.

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

H A Risch, J. Hopper, M. Southey, 2008, British Journal of Cancer.

High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.

Kerstin, Å. Borg, O. Johannsson, 2000, Journal of the National Cancer Institute.

Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer.

H. Grönberg, H. Olsson, J. Damber, 2000, European journal of cancer.

Indicators of prognosis in node-negative breast cancer.

M. Fernö, Å. Borg, H. Olsson, 1990, The New England journal of medicine.